Skip to main content

ORIGINAL RESEARCH article

Front. Genet.
Sec. Cancer Genetics and Oncogenomics
Volume 16 - 2025 | doi: 10.3389/fgene.2025.1536982
This article is part of the Research Topic Unraveling GI Cancer Heterogeneity Through Single-Cell Multi-Omics Approaches View all articles

Distinct gene signatures define the epithelial cell features of mucinous appendiceal neoplasms and pseudomyxoma metastases

Provisionally accepted
Carlos Ayala Carlos Ayala 1Anuja Sathe Anuja Sathe 2Xiangqi Bai Xiangqi Bai 2Susan Grimes Susan Grimes 2Jeanne Shen Jeanne Shen 3George Poultsides George Poultsides 1Byrne Lee Byrne Lee 1Hanlee P Ji Hanlee P Ji 2*
  • 1 Division of Surgical Oncology, Department of Surgery, Stanford University, Stanford, United States
  • 2 Division of Oncology, Department of Medicine, Stanford University, Stanford, United States
  • 3 Department of Pathology, School of Medicine, Stanford University, Palo Alto, California, United States

The final, formatted version of the article will be published soon.

    Appendiceal mucinous neoplasms (AMN) are rare tumors of the gastrointestinal tract. They metastasize with widespread abdominal dissemination leading to pseudomyxoma peritonei (PMP), a disease with poor prognosis. There are many questions about the cellular features of origin, differentiation and progression of AMN and PMP. Along these lines, we characterized AMNs, PMPs metastases and matched normal tissues using single-cell RNA-sequencing. We identified previously undescribed cellular features and heterogeneity in AMN and PMP tumors. There were specific gene expression signatures specific to the tumor epithelial cells among the AMN and PMP cells. These signatures included genes indicative of goblet cell differentiation and elevated mucin gene expression. Metastatic PMP cells had a distinct gene expression signature with increased lipid metabolism, inflammatory, JAK-STAT and RAS signaling pathway among others. We observed clonal heterogeneity in a single PMP tumor as well as PMP metastases from the same patient. Our findings were validated with immunohistochemistry, mass spectrometry on malignant ascites from PMP patients and gene expression data from an independent set of PMP tumors.

    Keywords: Pseudomyxoma, Appendiceal adenocarcinoma, Single-cell Transcriptome, Tumor heterogeneity (TH), Metasta sis

    Received: 29 Nov 2024; Accepted: 23 Jan 2025.

    Copyright: © 2025 Ayala, Sathe, Bai, Grimes, Shen, Poultsides, Lee and Ji. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

    * Correspondence: Hanlee P Ji, Division of Oncology, Department of Medicine, Stanford University, Stanford, United States

    Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.